[Fully bioresorbable scaffolds for coronary artery disease: systematic review]

Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
Record ID 32015000951
Authors' objectives: Coronary artery disease (CAD), which is a manifestation of atherosclerosis of the coronary arteries, belongs to the most prevalent diseases and it is the leading cause of death in Austria. Apart from an increased mortality risk, CAD is associated with recurring discomfort, impaired quality of life, and repeated hospitalisation.
Authors' recommendations: The current evidence is not sufficient to prove that the BVS is more or at least equally effective and safer than current revascularisation technologies. Hence, the inclusion in the catalogue of benefits is currently not recommended. We suggest re-evaluation in 2018.
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Austria
MeSH Terms
  • Humans
  • Coronary Artery Disease
  • Absorbable Implants
  • Tissue Scaffolds
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.